Topic:

R&D

Latest Headlines

Latest Headlines

With patent extension up for grabs, Shire agrees to test Vyvanse in preschoolers

To hear Shire tell it, there aren't many adequate and well-controlled drug studies in preschool-aged children with ADHD. But never fear, the company says: It's agreed to a written request by the FDA to investigate its ADHD drug Vyvanse in children aged 4 to 5, with a potential 6-month exclusivity boost for the drug on the line.

Mobile medical app brings laboratory testing to the home

As the number of mobile medical apps grows at a steady clip, companies are looking for innovative ways to streamline their products and reach consumers in their element. A new iOS device brings laboratory testing to the home, allowing individuals to test their vital levels with simple swabs of bodily fluids.

SARS enzyme finding could help advance MERS vaccine

In an important step toward the creation of a vaccine against deadly coronaviruses, researchers from Purdue University have figured out how to disable a key enzyme of the SARS virus that helps it hide from the immune system.

FDA gives nod to Covidien's detachable tip microcatheter device

The FDA has approved Covidien's new microcatheter, which the Ireland-based company says is the first detachable-tip device of its kind available in the U.S.

Boston Scientific says its deep brain stimulation device is showing promise

The market for deep brain stimulation to treat Parkinson's is heating up. Boston Scientific said its Vercise device is performed well in clinical trials. 

Billionaire Thiel backs biotech startups with eyes on Alzheimer's, GI disease

Breakout Labs, a science investing venture from PayPal billionaire Peter Thiel, is staking three biotechs at work on early-stage therapies for Alzheimer's disease, gastrointestinal disorders and bone surgery.

Avanir's nasal delivery for migraines beats oral sumatriptan in PhIIIb

Avanir Pharmaceuticals touted positive results from a Phase III trial of its AVP-825 sumatripan intranasal powder for migraines as compared with an oral formulation of the same treatment.

Massachusetts startup develops iOS app for autism

Mobile medical apps are quickly gaining ground as viable therapeutic tools, and a Massachusetts startup is using technology to create an iOS app that helps children with autism read emotions.

Celgene bets $25M on Soon-Shiong's personalized medicine play

Billionaire Patrick Soon-Shiong is working to marry Big Data and cancer treatment, and his old friends at Celgene have again stepped in to help out, investing $25 million in NantHealth, a cloud-based oncology brain trust.

Stem cells trapped in hydrogel better at bone repair

By encasing regenerative stems cells in a hydrophilic polymer, researchers at the University of Rochester were able to prevent them from leaving the repair site early, thereby speeding up the healing process.